Application of materials as medical devices with localized drug delivery capabilities for enhanced wound repair
Introduction
A wound constitutes any physical injury to the body arising from injuries, diseases, or surgical interventions, characterized by superficial lacerations or penetration to underlying tissues, such as muscles, ligaments or bones [1], [2]. Minor wounds often heal through the body’s intrinsic repair process that entails four consecutive phases: coagulation and hemostasis, inflammation, proliferation, and remodeling orchestrated by multiple cell populations (neutrophils, macrophages and fibroblasts), as well as through extracellular matrix formation and action of soluble mediators including growth factors and cytokines [3], [4]. Restoration is mostly impaired, however, in injuries of greater severity and may lead to wound exposure or tissue abnormalities [5], [6].
Consequently, materials frequently employed in the clinic are designed to stabilize the site of injury and aid in the healing process [7], [8], [9]. In order to be effective, wound repair devices should ideally possess similar mechanical properties to the tissue undergoing reconstruction [10], [11], [12]. Soft tissues (skin, tendon, ligaments, muscles) require more elastic and pliant materials such as polymers, as well as glues, sutures or dressings for wound closure [13], [14], [15], [16], [17]. On the other hand, stiff and strong materials, such as ceramics, metals and their alloys, are preferable for repairing hard tissues (bone, cartilage) [18], [19], [20], [21].
The need for wound repair devices continues to steadily increase with greater than 114 million patients worldwide enduring wounds from surgical procedures annually [22]. In the United States alone, 36 million patients experienced surgery-related wounds in 2012, and 31 million injured persons visited the emergency room in 2011 [23], [24]. The global wound care market totaled $15.6 billion in 2014 and is anticipated to grow to $18.3 billion by 2019 [25].
While many wound repair materials in current clinical use are reported to be effective, devastating wounds – mostly large defects – are highly susceptible to infection, pain, and abnormal inflammation [26], [27]. Cumbersome devices often employed for treatment may invoke secondary complications, such as foreign body reactions and chronic inflammation [28], [29], [30], [31], [32], [33]. Multiple administrations of oral or injectable drugs may therefore be prescribed to combat these issues [34], [35], [36]. Such strategies rely primarily on systemic drug exposure, which may not optimally address local wound complications [37], [38].
As a result, developing wound repair devices coupled with localized drug delivery represents an avenue of tremendous interest. This review begins with a general discussion on materials for wound repair and related complications that may arise. Subsequent sections focus on soft and hard tissues – each surveying the landscape for drug-eluting materials and their influence on different aspects of wound healing. Finally, perspectives on future directions in this field are offered.
Section snippets
Wound repair devices
To begin, wound repair devices can be categorized according to the mechanical properties of the damaged tissue, namely soft and hard (Figs. 1 and 2). Soft tissues include skin, muscle, tendon, and ligaments, which exhibit relatively high flexibility and elasticity [39], whereby in contrast, hard tissues consisting of bone or cartilage tend to have higher stiffness [40], [41].
Soft tissue wounds are inflicted via abrasion, laceration, avulsion, amputation, and penetration, as well as arising from
Device-related complications
Even after receiving appropriate treatment, large exposed wounds still face an array of complications, including infection [35], [93], [94], abnormal inflammation [95] and poor regeneration [96]. These issues lead to low patient compliance and prolonged hospitalization, which create a substantial socioeconomic burden [35], [93], [97], [98]. For instance, the overall cost of healthcare-associated infections in the United States ranges from $35.7 to $45.0 billion annually and involves roughly 1.8
Surgical sutures
Selecting the appropriate suture type for a patient remains essential but challenging. The nature of the soft tissue wound and any possible allergic reactions the individual may have to a given material must be taken into consideration. As mentioned in an earlier section, suture materials can be classified as absorbable or non-absorbable. Absorbable sutures are biodegradable and conveniently do not require subsequent removal. On occasion, they may potentially elicit inflammatory responses.
Orthopedic fixation devices
Fixation devices in the form of plates, rods, screws or pins afford stability during bone fracture repair (Table 3). The two modes of fixation are external and internal. External fixation involves positioning wires or pins (connected to rods) that penetrate the skin around the fracture [81]. Internal fixation aims to expedite the return of mobility and function at the site of injury, where the various implants may be directly attached to the bone fragments in need of repair [81]. Metals have
Perspectives on next-generation wound repair devices
The design and fabrication of efficient drug delivery materials remains of vital importance to the field of healthcare. As shown in previous work, medical devices have been used to administer a wide range of drugs and proteins to combat infection, modulate inflammation and enhance tissue regeneration. A pivotal role of drug-incorporated medical devices during the wound repair process is to provide mechanical strength at the site of injury, as well as to prevent undesirable biological
Conclusions
An array of medical devices has been developed to support the wound healing process. However, several complications still remain: infection, inflammation and limited tissue regeneration. In the past 15 years, many studies have focused on developing materials with local drug delivery capabilities to enhance soft and hard tissue wound repair. Various drug loading techniques such as dip coating, absorption and simple blending method have been successfully coupled with diverse materials to vary drug
Acknowledgments
Funding: This work was supported by the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), Ministry of Health & Welfare, Republic of Korea (HI15C1744 and HI14C2194) (YBC); the National Institutes of Health - United States (R01 AR068073 and R21 AR067527) (AGM); the Army, Navy, National Institutes of Health, Air Force, Veterans Affairs, and Health Affairs to support the AFIRM II effort under Award No. W81XWH-14-2-0004 (AGM); and a National Science
Esther J. Lee is a bioengineering Ph.D. student in the research group of Dr. Antonios G. Mikos at Rice University. She received her B.S.E. and M.S. degrees in biomedical engineering from Duke University in 2011 and 2012, respectively. Her current research focuses on leveraging optogenetic tools from synthetic biology for bone tissue engineering applications. Lee was the recipient of a National Science Foundation Graduate Research Fellowship (2012). To date, she has co-authored 14 peer-reviewed
References (241)
- et al.
Basic science of wound healing
Surgery (Oxford)
(2008) - et al.
Use of locking plates in the treatment of proximal humerus fractures
J Shoulder Elbow Surg
(2010) Advances in wound dressings
Clin Dermatol
(2007)Scaffolds in tissue engineering bone and cartilage
Biomaterials
(2000)- et al.
Glubran2 surgical glue: in vitro evaluation of adhesive and mechanical properties
J Surg Res
(2009) - et al.
Electrospinning of collagen nanofibers: effects on the behavior of normal human keratinocytes and early-stage wound healing
Biomaterials
(2006) - et al.
Biomedical applications of polymer-composite materials: a review
Compos Sci Technol
(2001) Mechanical properties of biomedical titanium alloys
Mater Sci Eng, A
(1998)- et al.
Surgical sealants and high strength adhesives
Mater Today
(2015) - et al.
Optimizing healing of the acute wound by minimizing complications
Curr Probl Surg
(2007)
Clavicular hook–plate: complications of retaining the implant
Injury
Foreign body reactions to resorbable poly(l-lactide) bone plates and screws used for the fixation of unstable zygomatic fractures
J Oral Maxillofac Surg
Drug/device combinations for local drug therapies and infection prophylaxis
Biomaterials
Wound healing dressings and drug delivery systems: a review
J Pharm Sci
Surgical adhesives: systematic review of the main types and development forecast
Prog Polym Sci
Wound dressings: principles and practice
Surgery (Oxford)
Suture materials: a review
Clin Mater
Selection of wound closure materials
J Am Acad Dermatol
Automatic disposable stapling devices for wound closure
Ann Emerg Med
Use of skin stapler in dermatologic surgery
J Am Acad Dermatol
Profiling surgical staplers: effect of staple height, buttress, and overlap on staple line failure
Surg Obes Relat Dis
Lactomer copolymer absorbable staples in gastrointestinal surgery
Am J Surg
Absorbable staples in continentileal urinary pouch
Urology
Fibrin structure and wound healing
J Thromb Haemost
The cyanoacrylate topical skin adhesives
Am J Emerg Med
BioGlue surgical adhesive—an appraisal of its indications in cardiac surgery
Ann Thorac Surg
Closure of long surgical incisions with a new formulation of 2-octylcyanoacrylate tissue adhesive versus commercially available methods
Am J Surg
Natural and synthetic polymers for wounds and burns dressing
Int J Pharm
Burn wound dressings—a review
Burns
Recent advances on the development of wound dressings for diabetic foot ulcer treatment—a review
Acta Biomater
A review of wound healing and wound dressing products
J Foot Ankle Surg
Treatment of dermal depth burn wounds with an antimicrobial agent-releasing silicone gel sheet
Burns
Novel chitosan wound dressing loaded with minocycline for the treatment of severe burn wounds
Int J Pharm
The use of a collagen sponge/living cell composite material to treat donor sites in burn patients
Burns
Effect of collagen matrices on dermal wound healing
Adv Drug Deliv Rev
The future of biologic coatings for orthopaedic implants
Biomaterials
The use of bioabsorbable implants in the spine
Spine J
Clinical biocompatibility of biodegradable orthopaedic implants for internal fixation: a review
Biomaterials
Synthetic biodegradable polymers as orthopedic devices
Biomaterials
Calcium phosphate cements as bone drug delivery systems: a review
J Control Release
Antibiotic-eluting medical devices for various applications
J Control Release
Triclosan-coated sutures for the reduction of sternal wound infections: economic considerations
Ann Thorac Surg
Bacterial adherence to surgical sutures: can antibacterial-coated sutures reduce the risk of microbial contamination?
J Am Coll Surg
Wound repair and regeneration
Nature
Wounds: biology and management
Wound healing–aiming for perfect skin regeneration
Science
Wound microbiology and associated approaches to wound management
Clin Microbiol Rev
Wound healing: an overview of acute, fibrotic and delayed healing
Front Biosci
Properties of acrylic bone cement: state of the art review
J Biomed Mater Res
Designing materials for biology and medicine
Nature
Cited by (0)
Esther J. Lee is a bioengineering Ph.D. student in the research group of Dr. Antonios G. Mikos at Rice University. She received her B.S.E. and M.S. degrees in biomedical engineering from Duke University in 2011 and 2012, respectively. Her current research focuses on leveraging optogenetic tools from synthetic biology for bone tissue engineering applications. Lee was the recipient of a National Science Foundation Graduate Research Fellowship (2012). To date, she has co-authored 14 peer-reviewed journal papers and 2 book chapters.
Beom Kang Huh is a bioengineering Ph.D. student in the research group of Dr. Young Bin Choy at Seoul National University. He received his B.S. (2011) in biomedical engineering from University of Wisconsin – Madison and his M.S. (2013) in bioengineering from the University of Pennsylvania. His current research focuses on the development of drug-loaded medical devices for various applications. Recently, he has co-authored 8 peer-reviewed journal papers.
Se Na Kim is a bioengineering Ph.D. student in the research group of Dr. Young Bin Choy at Seoul National University. She received her B.S.E. and M.S. degrees in chemical engineering from Inha University in 2007 and 2012, respectively. She is currently working on the fabrication of sustained drug delivery formulations using biocompatible polymer based nanoparticles and microparticles and metal-organic frameworks for glaucoma, pain and cancer therapy. To date, she has co-authored 11 peer-reviewed journal papers.
Jae Yeon Lee is a bioengineering M.S. student in the research group of Dr. Young Bin Choy at Seoul National University. She received her B.S.E. in biomedical engineering from Chung-Ang University in 2015. She is currently working on the delivery of biopolymer nanoparticles for ocular application. She has co-authored 2 peer-reviewed journal papers.
Chun Gwon Park received his B.S. (2009) from Hanyang University before earning his Ph.D. (2014) from Seoul National University under the supervision of Dr. Young Bin Choy in the department of biomedical engineering. Dr. Park’s graduate research dealt primarily with the design, fabrication, and evaluation of novel drug delivery devices. Specifically, he used nanofiber-structured biopolymers in order to achieve effective and sustained delivery of drugs at desired sites in the body. Dr. Park is currently a research fellow in the research group of Dr. Michael Goldberg at Harvard Medical School and Dana-Farber Cancer Institute, where he focuses mainly on biomaterial-based cancer immunotherapy. To date, Dr. Park has published 18 papers.
Dr. Antonios G. Mikos is the Louis Calder Professor of Bioengineering and Chemical and Biomolecular Engineering at Rice University. He obtained his Dipl. Eng. (1983) from the Aristotle University of Thessaloniki, Greece, followed by a Ph.D. (1988) in chemical engineering from Purdue University. Dr. Mikos conducted postdoctoral research at the Massachusetts Institute of Technology and Harvard Medical School until starting a faculty position at Rice University in 1992. His research encompasses biomaterials development, drug delivery, and gene therapy, with present emphasis on bone and cartilage tissue engineering. Dr. Mikos’ work has thus far garnered over 550 publications and 28 patents. Moreover, he has served as editor of 15 books and authored one textbook. Dr. Mikos has received numerous accolades, including the Lifetime Achievement Award from the Tissue Engineering and Regenerative Medicine International Society – Americas, the Founders Award of the Society for Biomaterials, and the Robert A. Pritzker Distinguished Lecturer Award of the Biomedical Engineering Society. He is a Member of the National Academy of Engineering, the National Academy of Medicine, the Academy of Medicine, Engineering, and Science of Texas, and the Academy of Athens, as well as a Fellow of the National Academy of Inventors.
Dr. Young Bin Choy is an Associate Professor in the Department of Biomedical Engineering at Seoul National University College of Medicine, Korea. He received his B.S. (1999) from Seoul National University, his M.S. (2000) in electrical engineering from University of Wisconsin – Madison and his Ph.D. (2006) in electrical engineering from University of Illinois at Urbana, Champaign. Dr. Choy worked as a postdoctoral fellow at the Georgia Institute of Technology until he became a faculty member at Seoul National University in 2009. His research is focused on developing biomaterial-based devices for various applications in medicine, such as drug delivery, tissue engineering and biomedical implants. Dr. Choy has published over 55 papers, and applied and issued over 40 patents. Dr. Choy has received the Young Biomedical Engineer Award and the Special Contribution Award from the Korean Society of Medical and Biological Engineering.
- 1
These authors contributed equally to this work.